Terns Pharmaceuticals Ownership | Who Owns Terns Pharmaceuticals?

Overview Forecast RevenueFinancials Chart

Terns Pharmaceuticals Ownership Summary

Terns Pharmaceuticals is owned by 102.15% institutional investors, 0.14% insiders. Orbimed advisors is the largest institutional shareholder, holding 10.23% of TERN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.46% of its assets in Terns Pharmaceuticals shares.

TERN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Terns Pharmaceuticals	102.15%	0.14%	-2.28%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Orbimed advisors	7.62M	10.23%	$51.89M
Vivo capital	6.18M	8.30%	$42.11M
Deep track capital, lp	6.10M	8.19%	$41.54M
Soleus capital management	4.95M	6.64%	$33.69M
Blackrock	4.12M	5.53%	$28.06M
Vr adviser	3.41M	4.58%	$23.22M
Fmr	2.77M	3.72%	$18.84M
Point72 asset management	2.69M	3.61%	$18.32M
Vanguard group	2.30M	3.09%	$15.67M
Schonfeld strategic advisors	2.27M	3.05%	$15.45M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Superstring capital management lp	956.54K	8.21%	$6.51M
Vivo capital	6.18M	3.89%	$42.11M
Soleus capital management	4.95M	2.97%	$33.69M
Acuta capital partners	369.28K	2.12%	$2.51M
Vr adviser	3.41M	1.48%	$23.22M
Timessquare capital management	621.64K	1.45%	$92.18M
Deep track capital, lp	6.10M	1.24%	$41.54M
Robeco schweiz	411.27K	1.17%	$60.99M
Orbimed advisors	7.62M	1.03%	$51.89M
Bridger management	246.80K	0.86%	$1.68M

Top Buyers

Holder	Shares	% Assets	Change
Soleus capital management	4.95M	2.97%	4.95M
Schonfeld strategic advisors	2.27M	0.10%	1.07M
Superstring capital management lp	956.54K	8.21%	956.54K
Blackrock	4.12M	0.00%	804.98K
Woodline partners lp	745.04K	0.05%	745.04K

Top Sellers

Holder	Shares	% Assets	Change
Janus henderson group	-	-	-2.00M
Octagon capital advisors lp	-	-	-1.36M
Suvretta capital management	-	-	-1.36M
Great point partners	-	-	-1.15M
Franklin resources	-	-	-1.12M

New Positions

Holder	Shares	% Assets	Change	Value
Soleus capital management	4.95M	2.97%	4.95M	$33.69M
Superstring capital management lp	956.54K	8.21%	956.54K	$6.51M
Woodline partners lp	745.04K	0.05%	745.04K	$5.07M
Parkman healthcare partners	390.27K	0.36%	390.27K	$2.66M
Salem investment counselors	371.60K	0.08%	371.60K	$2.53M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-9.00
Pnc financial services group	-17.00
Allworth financial lp	-90.00
National bank of canada /fi/	-100.00
Cubist systematic strategies	-327.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	165	17.86%	79,491,270	19.38%	102	1.28%	103	8.42%	38	65.22%
Jun 30, 2024	140	19.66%	66,584,833	5.52%	89	1.24%	95	48.44%	23	-28.13%
Mar 31, 2024	117	6.36%	63,102,304	-0.76%	84	1.10%	64	4.92%	32	39.13%
Dec 31, 2023	110	12.24%	63,584,999	3.76%	87	1.20%	61	48.78%	23	-36.11%
Sep 30, 2023	98	-11.71%	61,282,363	6.18%	85	1.31%	41	-41.43%	36	56.52%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.09M	2.46%	3.10K
iShares Russell 2000 ETF	1.47M	1.74%	-3.30K
Fidelity Select Biotechnology	1.09M	1.29%	1.09M
Fidelity Small Cap Growth	877.41K	1.04%	-1.09M
Nuveen Quant Small Cap Equity R6	830.73K	0.98%	-
Vanguard Institutional Extnd Mkt Idx Tr	680.99K	0.80%	-2.27K
HBM Healthcare Investments AG Ord	671.98K	0.80%	-
CREF Stock R1	635.70K	0.75%	178.80K
Fidelity Small Cap Index	589.55K	0.70%	-15.04K
T. Rowe Price New Horizons	512.26K	0.61%	512.26K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 05, 2024	Burroughs Amy L.	Chief Executive Officer	Buy	$110.47K
Sep 12, 2024	Lu Hongbo	-	Buy	$3.00M
Sep 12, 2024	Lu Hongbo	-	Buy	$2.00M
Sep 10, 2024	Vignola Mark J.	Chief Financial Officer	Sell	$110.00K
Sep 09, 2024	Quigley Jill M.	-	Sell	$172.35K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	2	18
2024 Q2	2	9
2024 Q1	-	-
2023 Q4	2	-

TERN Ownership FAQ

Who Owns Terns Pharmaceuticals?

Terns Pharmaceuticals shareholders are primarily institutional investors at 102.15%, followed by 0.14% insiders and -2.29% retail investors. The average institutional ownership in Terns Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Terns Pharmaceuticals exceeds.

Who owns the most shares of Terns Pharmaceuticals?

Terns Pharmaceuticals’s largest shareholders are Orbimed advisors (7.62M shares, 10.23%), Vivo capital (6.18M shares, 8.30%), and Deep track capital, lp (6.1M shares, 8.19%). Together, they hold 26.73% of Terns Pharmaceuticals’s total shares outstanding.

Does Blackrock own Terns Pharmaceuticals?

Yes, BlackRock owns 5.53% of Terns Pharmaceuticals, totaling 4.12M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 28.06M$. In the last quarter, BlackRock increased its holdings by 804.98K shares, a 24.28% change.

Who is Terns Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Superstring capital management lp is Terns Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 8.21% of its assets in 956.54K Terns Pharmaceuticals shares, valued at 6.51M$.

Who is the top mutual fund holder of Terns Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Terns Pharmaceuticals shares, with 2.46% of its total shares outstanding invested in 2.09M Terns Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools